Medical Expenditures and Earnings Losses Among US Adults With Arthritis in 2013
| Autor: | Edward H. Yelin, Charles G. Helmick, Miriam G. Cisternas, David J. Pasta, Louise B. Murphy |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Adolescent Cross-sectional study Psychological intervention Arthritis Young Adult 03 medical and health sciences 0302 clinical medicine Cost of Illness Rheumatology Ambulatory care medicine Humans 030212 general & internal medicine Economic impact analysis 030203 arthritis & rheumatology Earnings business.industry Middle Aged medicine.disease Cross-Sectional Studies Income Lower prevalence Health Expenditures Medical Expenditure Panel Survey business Demography |
| Zdroj: | Arthritis Care & Research. 70:869-876 |
| ISSN: | 2151-464X |
| DOI: | 10.1002/acr.23425 |
| Popis: | Objective We estimated the economic impact of arthritis using 2013 US Medical Expenditure Panel Survey (MEPS) data. Methods We calculated arthritis-attributable and all-cause medical expenditures for adults age ≥ 18 years and arthritis-attributable earnings losses among those 18-64 years who had ever worked. We calculated arthritis-attributable costs using multi-stage regression-based methods, and conducted sensitivity analyses to estimate costs for two other arthritis definitions in MEPS. Results In 2013, estimated total national arthritis-attributable medical expenditures were $139.8 billion (range= $135.9 - $157.5). Across expenditure categories, ambulatory care expenditures accounted for nearly half of arthritis-attributable expenditures. All-cause expenditures among adults with arthritis represented 51% of the $1.2 trillion national medical expenditures among all US adults in MEPS. Estimated total national arthritis-attributable earning losses were $163.7 billion (range= $163.7 - $170.0). The percentage with arthritis who worked in the past year was 7.2 percentage points lower than those without arthritis (76.8%; 95% CI= 75.0-78.6 and 84.0%; 95% CI= 82.5-85.5, respectively; adjusted for socio-demographics and chronic conditions). Total arthritis-attributable medical expenditures and earnings losses were $303.5 billion (range=$303.5 - $326.9). Conclusion Total national arthritis-attributable medical care expenditures and earnings losses among adults with arthritis were $303.5 billion in 2013. High arthritis-attributable medical expenditures might be reduced by greater efforts to reduce pain and improve function. The high earnings losses were largely attributable to the substantially lower prevalence of working among those with arthritis compared with those without, signaling the need for interventions that keep people with arthritis in the work force. This article is protected by copyright. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text